14MUSD
Type
Common Stock
Exchange
PINK
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
-
CUSIP
-
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
0.32
PEG Ratio
-
Book Value
0.00
Dividend Share
-
Dividend Yield
-
Earnings Share
0.022
Wall Street Target Price
-
EPS Estimate Current Year
-
EPS Estimate Next Year
-
EPS Estimate Current Quarter
0
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
7,262,185
Gross Profit TTM
4,770,398
EBITDA
1,783,146
Profit Margin
10.47%
Return On Assets TTM
9.43%
Return On Equity TTM
38.21%
Revenue Per Share TTM
0.012
Qtly Revenue Growth YOY
-16.30%
Diluted Eps TTM
0.022
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.32
Forward PE
0
Price Sales TTM
1.9274
Price Book MRQ
0
Enterprise Value Revenue
0
Enterprise Value EBITDA
0
419.72
4.35%153.92
3.92%1160.95
2.16%182.28
1.86%51.35
1.84%120.76
1.40%144.88
0.00%414.00
0.00%224.77
-0.08%238.33
-0.07%